IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Equity Capital Markets

Hangzhou SF Intra-city Industrial / Equity Capital Markets

Hangzhou SF Intra-city Industrial (9699 HK)

<ul>
<li>
<a href="https://www.smartkarma.com/entities/hangzhou-sf-intra-city-industrial-co-ltd" target="_blank" data-smartkarma-citation="entities:34916:1" rel="noopener">SF Intra-City (9699 HK)</a> is the largest Chinese independent third-party on-demand delivery service provider. It launched an HKEx IPO to raise net proceeds of $273 million at the IPO mid-point. </li>
<li>In <a href="https://www.smartkarma.com/insights/sf-intra-city-industrial-ipo-delivering-losses" target="_blank" data-smartkarma-citation="insights:61272" rel="noopener">SF Intra-City Industrial IPO: Delivering Losses</a>, we noted that SF Intra-city’s fundamentals are less than inspiring. </li>
<li>While the valuation is undemanding vs peers, we give the IPO a pass as SF Intra-city offers an unappetizing mix of high growth at the cost of losses/cash burn.   </li>
</ul>



SF Intra-City (9699 HK) is the largest Chinese independent third-party on-demand delivery service provider. It launched an HKEx IPO to raise net proceeds of $273 million at the IPO mid-point. 
In SF Intra-City Industrial IPO: Delivering Losses, we noted that SF Intra-city’s fundamentals are less than inspiring. 
While the valuation is undemanding vs peers, we give the IPO a pass as SF Intra-city offers an unappetizing mix of high growth at the cost of losses/cash burn.   


SF Intra-City Industrial IPO: Valuation Insights

APAC IPOs & Placements, Aequitas Research

Clarence Chu

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/gushengtang-cayman-ltd" target="_blank" data-smartkarma-citation="entities:33503:1" rel="noopener">Gushengtang (GUS HK)</a> is looking to raise up to US$104m in its Hong Kong IPO. </li>
<li>While there isn’t anything fundamentally wrong with the deal, valuation is at a premium, despite having margins towards the bottom end of its peer set.</li>
<li>Pre-IPO investors, from Mar 2021, would have made gains on listing as well and could remain an overhang post-listing.</li>
</ul>



Gushengtang (GUS HK) is looking to raise up to US$104m in its Hong Kong IPO. 
While there isn’t anything fundamentally wrong with the deal, valuation is at a premium, despite having margins towards the bottom end of its peer set.
Pre-IPO investors, from Mar 2021, would have made gains on listing as well and could remain an overhang post-listing.


Gushengtang IPO - Wide Valuation Gap from Peers

Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

<ul>
<li>
<a href="https://www.smartkarma.com/entities/hangzhou-sf-intra-city-industrial-co-ltd" target="_blank" data-smartkarma-citation="entities:34916:1" rel="noopener">SF Intra-City (9699 HK)</a> (SFIC) is looking to raise up to about US$300m in its Hong Kong IPO.</li>
<li>SFIC is the intra-city on-demand delivery arm of SF Holding.</li>
<li>Valuation is expensive compared to <a href="https://www.smartkarma.com/entities/dada-nexus-ltd" target="_blank" data-smartkarma-citation="entities:28961:1" rel="noopener">Dada Nexus Ltd (DADA US)</a>. </li>
</ul>



SF Intra-City (9699 HK) (SFIC) is looking to raise up to about US$300m in its Hong Kong IPO.
SFIC is the intra-city on-demand delivery arm of SF Holding.
Valuation is expensive compared to Dada Nexus Ltd (DADA US). 


SF Intra-City (顺丰同城) IPO - Not the Right Price

<ul>
<li>
<a href="https://www.smartkarma.com/entities/gushengtang-cayman-ltd" target="_blank" data-smartkarma-citation="entities:33503:1" rel="noopener">Gushengtang (GUS HK)</a> is looking to raise US$150m in its Hong Kong IPO.</li>
<li>Gushengtang is a traditional chinese medicine (TCM) healthcare service provider in China. It provides TCM healthcare services and products via its offline medical institutions and online healthcare platforms.</li>
<li>As of the LPD, the firm provided services to customers across 31 provinces via its medical service network, and had 19,203 physicians practicing as of Jun 2021.</li>
</ul>



Gushengtang (GUS HK) is looking to raise US$150m in its Hong Kong IPO.
Gushengtang is a traditional chinese medicine (TCM) healthcare service provider in China. It provides TCM healthcare services and products via its offline medical institutions and online healthcare platforms.
As of the LPD, the firm provided services to customers across 31 provinces via its medical service network, and had 19,203 physicians practicing as of Jun 2021.


Gushengtang Pre-IPO - The Negatives - Small Player in a Fragmented Market

Gushengtang Pre-IPO - The Positives - Resilient Financials and Could Ride on Industry Tailwind

China

Hangzhou SF Intra-city Industrial Co., Ltd. provides intra-city on-demand delivery services across China, covering food, fresh produce, electronics, and other goods for merchants, consumers, and logistics companies. The company also offers software development and IT services. Founded in 2016, it began independent operations in 2019 and is headquartered in Shenzhen, China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Hangzhou SF Intra-city Industrial (9699 HK)

SF Intra-City Industrial IPO: Valuation Insights

While the valuation is undemanding vs peers, we give the IPO a pass as SF Intra-city offers an unappetizing mix of high growth at the cost of...

Arun George

Gushengtang IPO - Wide Valuation Gap from Peers

Gushengtang (GUS HK) is looking to raise up to US$104m in its Hong Kong IPO. Valuation comes in at a premium, despite having margins towards the...

Clarence Chu

SF Intra-City (顺丰同城) IPO - Not the Right Price

Hangzhou SF Intra-City (SFIC) is looking to raise up to about US$300m in its Hong Kong IPO. Our valuation implies 11 - 38% potential downside to...

Sumeet Singh

Gushengtang Pre-IPO - The Negatives - Small Player in a Fragmented Market

Gushengtang (GUS HK) is looking to raise US$150m in its Hong Kong IPO. The firm provides TCM healthcare services and products via its offline...

Clarence Chu

Gushengtang Pre-IPO - The Positives - Resilient Financials and Could Ride on Industry Tailwind

Gushengtang (GUS HK) is looking to raise US$150m in its Hong Kong IPO. The firm is a traditional chinese medicine (TCM) healthcare service provider...

Clarence Chu

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)